VCANBIO CELL & GENE ENGINEERING CORP., LTD

Other languages Vcanbio Cell & Gene Engineering Corp., Ltd

Equities

600645

CNE000000545

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 28/04/2024 BST			5-day change	1st Jan Change
16.97 ^CNY	+3.16%		+8.50%	-16.28%

04-25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-25
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25
Vcanbio Cell & Gene Engineering Corp., Ltd announces an Equity Buyback for CLP 200 million worth of its shares.	02-19
Vcanbio Cell & Gene Engineering Corp., Ltd authorizes a Buyback Plan	02-16
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Vcanbio Cell & Gene Gets Greenlight to Trial COVID-19 Drug	16/10/23
MET Group signs energy supply deal with Commonwealth LNG	04/09/23
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Vcanbio Cell & Gene’s Pulmonary Fibrosis Treatment Wins Orphan Drug Designation in US	14/08/23
Vcanbio Cell & Gene Unit Gets Nod to Begin Clinical Trial of Respiratory Distress Medication	08/06/23
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23
Vcanbio Cell & Gene Engineering Wins Nod to Trial Stem Cell Therapy For Liver Cirrhosis	13/02/23
C-Mer Eye Care Raises HK$116.1 Million in Share Subscription Deal	09/12/22
C-Mer Eye Care To Issue More Than 30 Million New Shares to Vcanbio Cell Chairman	05/12/22
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Energy firms MET and HH2E to invest in Baltic electrolysis plant	15/06/22
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	24/04/22
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	24/04/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vcanbio Cell & Gene Engineering Corp., Ltd

Equities

600645

CNE000000545

Other languages

Filters